当前对免疫性血小板缺血的理解:对病原和治疗选择的审查
相关实验视频
Updated: Jul 2, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.7K
Alina Mititelu1, Minodora-Cezarina Onisâi1, Adrian Roșca2
1Department of Hematology, Carol Davila University of Medicine and Pharmacy, Emergency University Hospital of Bucharest, 050098 Bucharest, Romania.
International journal of molecular sciences
|February 24, 2024
概括
由于其不可预测的性质和缺乏响应预测因子,管理免疫血小板缺血症 (ITP) 仍然具有挑战性. 新的向疗法有希望,但为了更好的患者结果,需要个性化治疗算法.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫性血小板缺血 (ITP) 是一种异质的血液学疾病,进展不可预测.
- 慢性ITP影响高达75%的成年患者,显著影响生活质量.
- 在ITP中,特别是血小板数量较低时,出血风险需要进一步澄清.
研究的目的:
- 审查免疫性血小板缺血症 (ITP) 的当前管理策略.
- 为突出ITP新兴的向治疗方法.
- 确定对预测因素的需求,以优化ITP治疗算法.
主要方法:
- 关于ITP病原和治疗的当前文献的综述.
- 对现有治疗方法的分析,包括免疫抑制,TPO-RAs,rituximab和Syk抑制剂.
- 讨论正在开发的新型向疗法.
主要成果:
- 目前的ITP管理依赖于免疫抑制和已确定的向药物.
- 像BTK抑制剂和Fc受体对抗剂这样的新疗法对疗效和耐受性有希望.
- 随着较新的治疗方法,观察到患者生活质量的显著改善.
结论:
- 尽管取得了进展,但预测患者对ITP疗法的反应仍然是一个重大挑战.
- 对预测因素的进一步研究对于开发优化,个性化的治疗算法至关重要.
- 向疗法正在改善ITP患者的治疗结果和生活质量.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906

